TRISTA GROSSNICKLE: Open Payments
NPI 1346993763 · CLARINDA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 14 payments from 9 companies in 2025. Trend: 2023 $252 · 2024 $168 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $99 |
| Alkermes, Inc. | 3 | $48 |
| ABBVIE INC. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: INVEGA SUSTENNA, ARISTADA, VRAYLAR, Jornay PM, REXULTI, CAPLYTA, TRINTELLIX, COBENFY.
Industry payments across IA — which companies pay providers there.
